UVEITIS
Clinical trials for UVEITIS explained in plain language.
Never miss a new study
Get alerted when new UVEITIS trials appear
Sign up with your email to follow new studies for UVEITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with Arthritis-Related eye disease?
Disease control OngoingThis study tests a daily pill called baricitinib for children aged 2 to 18 with active uveitis (eye inflammation) linked to juvenile arthritis or a related condition. The goal is to see if it safely reduces eye inflammation better than current treatments. About 30 participants wh…
Matched conditions: UVEITIS
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 08, 2026 13:10 UTC
-
Eye fluid clues may guide uveitis treatment
Knowledge-focused OngoingThis study examines whether proteins in eye fluid can help doctors choose the right immunosuppressive drug for people with non-infectious uveitis, a type of eye inflammation. About 220 participants who haven't responded well to steroids will provide eye fluid and blood samples. R…
Matched conditions: UVEITIS
Phase: NA • Sponsor: University of Milan • Aim: Knowledge-focused
Last updated Jun 17, 2026 07:14 UTC
-
Singapore eye study seeks patterns in inflammation
Knowledge-focused OngoingThis study reviews medical records of 200 people in Singapore with eye inflammation diseases like uveitis and scleritis. Researchers want to learn who gets these conditions, what treatments they receive, and how they do over time. The goal is to better understand these diseases i…
Matched conditions: UVEITIS
Sponsor: Singapore National Eye Centre • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:02 UTC